PMC:7796052 / 16251-16506
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 415 | 110-114 | Gene | denotes | IL-6 | Gene:3569 |
| 416 | 115-120 | Gene | denotes | STAT3 | Gene:6774 |
| 417 | 198-207 | Species | denotes | SARS-Cov2 | Tax:2697049 |
| 419 | 62-72 | Chemical | denotes | raloxifene | MESH:D020849 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T113 | 0-255 | Sentence | denotes | Present results support previous claims suggesting the use of raloxifene based on its capacity to inhibit the IL-6/STAT3 signaling pathway [45], and also for being a prospective antiviral agent for SARS-Cov2 as inhibitor of the two-pore channel TCP2 [48]. |